Symeres has entered a collaboration with Ambagon Therapeutics on molecular glue research in colorectal cancer, aiming to ...
Symeres, Ambagon Therapeutics collaborate on molecular glue research in colorectal cancer: Nijmegen, Netherlands Thursday, April 2, 2026, 12:00 Hrs [IST] Symeres, a leading CRDMO ...
Symeres and Ambagon Therapeutics collaborate on molecular glue research in colorectal cancerNijmegen, Netherlands [31.03.2026] – Symeres, a leading CRDMO for drug discovery and development has ...
Draupnir's novel SORTAC platform expands reach of targeted protein degradation to extracellular proteins, demonstrating in vitro and in vivo efficacy against difficult-to-drug targetsStudy further det ...
The research aims to develop insights into colorectal cancer A leading CRDMO for drug discovery and development Symeres has partnered with Ambagon Therapeutics, a pre-clinical biotechnology company, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results